Hans Ibsen

Effects of telmisartan, irbesartan, valsartan, candesartan, and losartan on cancers in 15 trials enrolling 138 769 individuals

Karl Swedberg, Richard B. Devereux, Ralph L. Sacco, 2011, Journal of hypertension.

Stroke Reduction in Hypertensive Adults With Cardiac Hypertrophy Randomized to Losartan Versus Atenolol: The Losartan Intervention For Endpoint Reduction in Hypertension Study

Katherine E. Harris, Richard B. Devereux, Hans Wedel, 2005, Hypertension.

Prognostic accuracy of day versus night ambulatory blood pressure: a cohort study

Yan Li, Lars Lind, Yutaka Imai, 2007, The Lancet.

P-74: Does optimal or normal blood pressure in the office rule out ambulatory hypertension?

T. Hansen, J. Jeppesen, C. Torp‐Pedersen, 2005 .

Prognostic Value of Aortic Pulse Wave Velocity as Index of Arterial Stiffness in the General Population

Tine Willum Hansen, Jan A. Staessen, Lutgarde Thijs, 2006, Circulation.

Ambulatory blood pressure monitoring and risk of cardiovascular disease: a population based study.

Tine Willum Hansen, T. Hansen, J. Jeppesen, 2006, American journal of hypertension.

A randomized non-pharmacological intervention study for prevention of ischaemic heart disease: baseline results Inter99 (1)

Charlotte Glümer, T. Jørgensen, K. Borch-Johnsen, 2003, European journal of cardiovascular prevention and rehabilitation : official journal of the European Society of Cardiology, Working Groups on Epidemiology & Prevention and Cardiac Rehabilitation and Exercise Physiology.

Cardiovascular morbidity and mortality in patients with diabetes in the Losartan Intervention For Endpoint reduction in hypertension study (LIFE): a randomised trial against atenolol

Steven Snapinn, Ulf de Faire, Richard B Devereux, 2002, The Lancet.

Ambulatory Blood Pressure and Mortality: A Population-Based Study

Tine Willum Hansen, T. Hansen, J. Jeppesen, 2005, Hypertension.